CHANGMAO BIOCHEM-H-
CHANGMAO BIOCHEM-H- operates in Diversified Metals & Mining.
CHANGMAO BIOCHEM-H- (CZB) - Net Assets
Latest net assets as of December 2023: €651.59 Million EUR
Based on the latest financial reports, CHANGMAO BIOCHEM-H- (CZB) has net assets worth €651.59 Million EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.24 Billion) and total liabilities (€590.91 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €651.59 Million |
| % of Total Assets | 52.44% |
| Annual Growth Rate | 1.46% |
| 5-Year Change | -1.62% |
| 10-Year Change | N/A |
| Growth Volatility | 8.76 |
CHANGMAO BIOCHEM-H- - Net Assets Trend (2016–2023)
This chart illustrates how CHANGMAO BIOCHEM-H-'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CHANGMAO BIOCHEM-H- (2016–2023)
The table below shows the annual net assets of CHANGMAO BIOCHEM-H- from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €651.59 Million | -16.34% |
| 2022-12-31 | €778.89 Million | +11.67% |
| 2021-12-31 | €697.53 Million | +7.33% |
| 2020-12-31 | €649.91 Million | -1.87% |
| 2019-12-31 | €662.31 Million | +4.98% |
| 2018-12-31 | €630.87 Million | +8.59% |
| 2017-12-31 | €580.96 Million | -1.34% |
| 2016-12-31 | €588.85 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CHANGMAO BIOCHEM-H-'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 15.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €407.42 Million | 62.52% |
| Other Components | €244.27 Million | 37.48% |
| Total Equity | €651.69 Million | 100.00% |
CHANGMAO BIOCHEM-H- Competitors by Market Cap
The table below lists competitors of CHANGMAO BIOCHEM-H- ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Osool ESB Securities Brokerage
EGX:EBSC
|
$297.42 |
|
B-Scada Inc
PINK:SCDA
|
$297.72 |
|
Marechale Capital Plc
LSE:MAC
|
$297.92 |
|
Altern Energy Ltd
KAR:ALTN
|
$298.56 |
|
Evocati Capital Resources Inc.
V:EVOC-P
|
$297.18 |
|
Atok Big Wedge Co Inc
PSE:AB
|
$297.15 |
|
Distil Plc
LSE:DIS
|
$296.95 |
|
Bimi International Medical Inc
OTCMKTS:BIMI
|
$296.83 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CHANGMAO BIOCHEM-H-'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 778,531,000 to 651,688,000, a change of -126,843,000 (-16.3%).
- Net loss of 86,057,000 reduced equity.
- Dividend payments of 42,332,000 reduced retained earnings.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-86.06 Million | -13.21% |
| Dividends Paid | €42.33 Million | -6.5% |
| Other Changes | €1.55 Million | +0.24% |
| Total Change | €- | -16.29% |
Book Value vs Market Value Analysis
This analysis compares CHANGMAO BIOCHEM-H-'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €1.09 | €0.03 | x |
| 2018-12-31 | €1.19 | €0.03 | x |
| 2019-12-31 | €1.25 | €0.03 | x |
| 2020-12-31 | €1.23 | €0.03 | x |
| 2021-12-31 | €1.32 | €0.03 | x |
| 2022-12-31 | €1.47 | €0.03 | x |
| 2023-12-31 | €1.23 | €0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CHANGMAO BIOCHEM-H- utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.21%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.51%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 1.91x
- Recent ROE (-13.21%) is below the historical average (3.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 5.66% | 5.58% | 0.88x | 1.15x | €-25.48 Million |
| 2017 | 0.58% | 0.54% | 0.86x | 1.26x | €-54.55 Million |
| 2018 | 8.02% | 7.91% | 0.87x | 1.16x | €-12.46 Million |
| 2019 | 8.81% | 11.79% | 0.67x | 1.11x | €-7.87 Million |
| 2020 | 2.59% | 3.79% | 0.52x | 1.30x | €-48.11 Million |
| 2021 | 8.37% | 10.64% | 0.57x | 1.37x | €-11.39 Million |
| 2022 | 10.46% | 11.15% | 0.60x | 1.55x | €3.57 Million |
| 2023 | -13.21% | -13.51% | 0.51x | 1.91x | €-151.23 Million |
Industry Comparison
This section compares CHANGMAO BIOCHEM-H-'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CHANGMAO BIOCHEM-H- (CZB) | €651.59 Million | 5.66% | 0.91x | $297.20 |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |